Illumina Inc/ US4523271090 /
30/08/2024 22:00:00 | Chg. -2.3800 | Volume | Bid23:16:09 | Ask23:16:09 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
131.4000USD | -1.78% | 968,971 Turnover: 81.53 mill. |
131.4000Bid Size: 1,000 | 133.2000Ask Size: 100 | 20.93 bill.USD | - | - |
GlobeNewswire
01/08
Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies i...
GlobeNewswire
29/07
Palisade Bio Successfully Completes Microbiome Study Confirming Bacterial Enzymes for Local Bioactiv...
GlobeNewswire
23/07
Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing
GlobeNewswire
09/07
Paragon Genomics Partners with Biosecure ID to Expand Access to CleanPlex® Technology in the UK and ...
GlobeNewswire
20/06
Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research
GlobeNewswire
03/06
AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen a...
GlobeNewswire
29/05
QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision ...
GlobeNewswire
09/05
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alte...
GlobeNewswire
04/03
Baylor Genetics to Share Scientific and Clinical Insights on AI, Precision Diagnostics, Carrier Scre...
GlobeNewswire
27/02
ILLUMINA ALERT: Bragar Eagel & Squire, P.C. is Investigating Illumina, Inc. on Behalf of Long-Term S...
GlobeNewswire
09/01
DEADLINE ALERT for PAYC, ILMN, and JRVR: The Law Offices of Frank R. Cruz Reminds Investors of Class...
GlobeNewswire
09/01
ILMN DEADLINE TODAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors with Lo...
GlobeNewswire
08/01
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Illumina, Inc. (ILMN) Investors of a Class Action Lawsu...
Newsfile Corp
06/01
ILMN DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel...